IFCI Limited has submitted to the Exchange, the financial results for the period ended June 30, 2025.
IFCI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Smallcap 250 and 1.5 pts less than its Financial Institution peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
IFCI Limited submitted its unaudited financial results for Q1 FY26, showing a strong turnaround on the bottom line. On a standalone basis, total income rose to ₹180.86 crore from ₹123.19 crore a year ago, while profit after tax swung to ₹7.38 crore from a loss of ₹148.24 crore, driven by lower finance costs (₹102.61 cr vs ₹134.39 cr) and a ₹58.64 crore gain on fair value changes. Consolidated PAT also turned positive at ₹62.43 crore versus a loss of ₹87.17 crore. However, serious concerns remain: CRAR is deeply negative at (-)21.85% (well below RBI norms), Gross NPAs stand at an alarming 96.05%, and provisioning under RBI prudential norms exceeds Ind AS impairment by ₹85.88 crore. The government infused ₹500 crore via a preferential issue in early 2025, and an in-principle approval exists for consolidating the IFCI Group through merger/amalgamation. Auditor S Mann & Co. issued an unqualified review report but included multiple Emphasis of Matter paragraphs flagging the negative CRAR, sub-judice SHCIL litigation, valuation of subsidiaries, and a conflict-of-interest concern around the SDF scheme.
The headline swing to profit is encouraging for shareholders, but the underlying asset quality is extremely weak — 96% of loans are NPAs and capital adequacy is negative, meaning the company is technically under-capitalised relative to RBI norms. The ₹500 crore GoI infusion and ongoing group consolidation plan are key positive triggers, though execution risk remains high. Short-term stock reaction may be mixed.